Funded Startups in Manassas
Manassas entries skew toward mid-sized, disclosed financings, with one clear outlier: RangeForce’s $20M Series B (2023-03-06) is the largest disclosed amou…
Manassas entries skew toward mid-sized, disclosed financings, with one clear outlier: RangeForce’s $20M Series B (2023-03-06) is the largest disclosed amount, well above Ceres Nanosciences ($5M on 2022-09-09), ATCC ($6M on 2022-02-15), and Benten Technologies ($4M on 2021-10-01). The next-largest disclosed round ($6M) sits far below that top figure, while one firm (Jeeva, 2023-06-27) shows a much smaller disclosed amount of $80K.
The time window for these six most recent rows runs from 2021-10-01 (Benten Technologies) to 2026-02-23 (ARG, Inc), with three of the six entries occurring in 2023 (Jeeva, 2023-06-27; RangeForce, 2023-03-06; and ARG, Inc is the 2026-02-23 outlier). Biotech is the dominant sector in this set, appearing in three entries (Jeeva; Ceres Nanosciences; ATCC). Stage labeling is fragmented: five of the six rows are marked as “Series Unknown,” “Venture - Series Unknown,” or “undisclosed,” while only RangeForce is labeled Series B.
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in Manassas here, and how does it compare to the other disclosed amounts?
RangeForce’s $20M Series B on 2023-03-06 is the largest disclosed amount. It dwarfs the rest of the disclosed figures, where the next-highest is ATCC’s $6M (2022-02-15), followed by Ceres Nanosciences at $5M (2022-09-09) and Benten Technologies at $4M (2021-10-01).
Is there a cluster in time among these six most recent Manassas rows?
Yes. Three entries are concentrated in 2023: RangeForce ($20M) on 2023-03-06 and Jeeva ($80K) on 2023-06-27 are both in that year, and the same 2023 cluster is also reflected by the second 2023-dated entry in the list’s window (with all other disclosed rounds dated 2022 or earlier).
Which sectors appear most often in this Manassas slice, and do any sectors look under- or over-represented?
Biotechnology is over-represented relative to other sectors in this list, with 3 of the 6 rows in biotech: Jeeva (2023-06-27, $80K), Ceres Nanosciences (2022-09-09, $5M), and ATCC (2022-02-15, $6M). The remaining entries split between Hardware (ARG, Inc, 2026-02-23, undisclosed), Education (RangeForce, 2023-03-06, $20M), and Health Care (Benten Technologies, 2021-10-01, $4M).
How dominant is “Series Unknown” or undisclosed staging in these rows?
Staging is overwhelmingly non-specific: five of six rows are either “Series Unknown,” “Venture - Series Unknown,” or “undisclosed” (ARG, Inc; Jeeva; Ceres Nanosciences; ATCC; and Benten Technologies). Only RangeForce is labeled with a specific stage (Series B, 2023-03-06, $20M).
Are there outliers worth separating from the rest in amount and/or sector?
Two outliers stand out. Amount-wise, RangeForce’s $20M (2023-03-06) is far above the rest of the disclosed amounts, while Jeeva’s $80K (2023-06-27) is much smaller than the $4M–$6M range of ATCC and the 2021/2022 entries (Benten Technologies $4M on 2021-10-01; ATCC $6M on 2022-02-15; Ceres Nanosciences $5M on 2022-09-09).
Which entries fall near the most recent date edge in this dataset?
The list’s most recent row is ARG, Inc on 2026-02-23 (Hardware, undisclosed). The next-closest dated entry is Jeeva on 2023-06-27 ($80K), with RangeForce on 2023-03-06 ($20M) and Ceres Nanosciences on 2022-09-09 ($5M) forming the next steps back in time.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.